Preclinical models for investigating how bone marrow adipocytes influence bone and hematopoietic cellularity.

Szczegóły
Abstrakt

Tytuł:: Preclinical models for investigating how bone marrow adipocytes influence bone and hematopoietic cellularity.
Autorzy:: Li Z; Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA.
MacDougald OA; Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: .
Źródło:: Best practice & research. Clinical endocrinology & metabolism [Best Pract Res Clin Endocrinol Metab] 2021 Jul; Vol. 35 (4), pp. 101547. Date of Electronic Publication: 2021 May 01.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
Język:: English
Imprint Name(s):: Publication: 2002- : Amsterdam : Elsevier
Original Publication: Amsterdam : Harcourt Publishers, c2001-
MeSH Terms:: Bone Marrow Cells*
Disease Models, Animal*
Adipocytes ; Animals ; Bone Marrow ; Bone and Bones ; Humans ; Mice
References:: J Clin Endocrinol Metab. 2008 Jun;93(6):2281-6. (PMID: 18381577)
AJR Am J Roentgenol. 2008 Oct;191(4):987-94. (PMID: 18806132)
BMC Cancer. 2018 Oct 11;18(1):972. (PMID: 30309324)
Bone. 2004 Jan;34(1):148-56. (PMID: 14751572)
Regul Pept. 2000 Aug 25;92(1-3):73-8. (PMID: 11024568)
Int J Cancer. 2008 Mar 15;122(6):1418-21. (PMID: 18027857)
Skeletal Radiol. 1985;14(1):10-9. (PMID: 3895447)
J Magn Reson Imaging. 2001 Feb;13(2):263-8. (PMID: 11169833)
J Immunol. 2003 Sep 1;171(5):2326-30. (PMID: 12928378)
Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. (PMID: 22123971)
J Bone Miner Res. 2015 May;30(5):920-8. (PMID: 25400253)
Endocrinology. 2008 Feb;149(2):634-41. (PMID: 17991723)
Nat Commun. 2020 Jun 18;11(1):3097. (PMID: 32555194)
Aging Cell. 2020 Nov;19(11):e13247. (PMID: 33048436)
J Nutr Gerontol Geriatr. 2019 Jan-Mar;38(1):100-114. (PMID: 30794099)
J Bone Miner Res. 2005 Jul;20(7):1085-92. (PMID: 15940361)
Quant Imaging Med Surg. 2018 Feb;8(1):60-85. (PMID: 29541624)
J Clin Endocrinol Metab. 2012 Apr;97(4):1337-46. (PMID: 22319043)
J Bone Miner Res. 2015 Nov;30(11):2058-66. (PMID: 25982922)
Oral Surg Oral Med Oral Pathol. 1987 Oct;64(4):379-90. (PMID: 3477756)
Bone. 2018 May;110:134-140. (PMID: 29343445)
PLoS Genet. 2019 Jun 24;15(6):e1008244. (PMID: 31233501)
J Bone Miner Res. 2008 Jun;23(6):870-8. (PMID: 18435579)
Mol Metab. 2018 Apr;10:55-65. (PMID: 29459250)
Bone. 2004 Mar;34(3):376-83. (PMID: 15003785)
Bone. 1991;12(2):123-31. (PMID: 2064840)
J Clin Endocrinol Metab. 2014 Jun;99(6):2155-63. (PMID: 24606073)
Haematologica. 2018 Jan;103(1):e21-e24. (PMID: 29051282)
Endocrinology. 2002 Jun;143(6):2376-84. (PMID: 12021203)
Cancer Res. 2009 Oct 1;69(19):7867-74. (PMID: 19773440)
Leuk Res. 2012 Jul;36(7):868-75. (PMID: 22285508)
Bone. 2014 Oct;67:33-40. (PMID: 24998454)
Bone. 2010 Jan;46(1):101-11. (PMID: 19747571)
J Appl Physiol (1985). 2006 Sep;101(3):789-93. (PMID: 16741258)
Int J Radiat Biol. 1995 Dec;68(6):669-78. (PMID: 8551110)
Front Endocrinol (Lausanne). 2020 Sep 24;11:480. (PMID: 33071956)
J Clin Densitom. 2018 Jan - Mar;21(1):61-67. (PMID: 27894728)
Bone. 2019 Jan;118:69-76. (PMID: 29331301)
J Clin Endocrinol Metab. 2010 Jan;95(1):134-42. (PMID: 19875477)
Radiology. 1990 Apr;175(1):219-23. (PMID: 2315484)
J Exp Med. 2000 Nov 6;192(9):1273-80. (PMID: 11067876)
N Engl J Med. 1984 Dec 20;311(25):1601-6. (PMID: 6504095)
Methods Enzymol. 2014;537:123-39. (PMID: 24480344)
Endocrinology. 2009 Mar;150(3):1330-40. (PMID: 18948404)
Radiat Res. 2013 Jul;180(1):89-99. (PMID: 23772924)
N Engl J Med. 2004 Sep 9;351(11):1106-18. (PMID: 15356308)
J Magn Reson Imaging. 2012 Jul;36(1):225-30. (PMID: 22337076)
Exp Ther Med. 2018 Apr;15(4):3623-3632. (PMID: 29545892)
Leukemia. 2007 Jul;21(7):1580-4. (PMID: 17377589)
Cell Stem Cell. 2017 Jun 1;20(6):771-784.e6. (PMID: 28330582)
Nature. 2015 Sep 17;525(7569):380-3. (PMID: 26331539)
J Clin Endocrinol Metab. 2011 May;96(5):1541-8. (PMID: 21367933)
J Bone Miner Res. 2007 Sep;22(9):1408-18. (PMID: 17550335)
J Bone Miner Res. 2018 Jan;33(1):99-112. (PMID: 28902435)
J Clin Endocrinol Metab. 1989 Mar;68(3):548-54. (PMID: 2493036)
Front Endocrinol (Lausanne). 2016 Jul 27;7:102. (PMID: 27512386)
Nat Immunol. 2004 Feb;5(2):133-9. (PMID: 14749784)
Mol Cell Endocrinol. 2015 Jul 15;410:35-41. (PMID: 25576855)
J Osteoporos. 2015;2015:152349. (PMID: 25969766)
Med Glas (Zenica). 2020 Feb 1;17(1):15-21. (PMID: 31719507)
Bone Miner. 1991 Jun;13(3):217-33. (PMID: 1863810)
Semin Oncol. 2004 Apr;31(2):185-97. (PMID: 15112149)
Arch Pathol Lab Med. 1976 Jan;100(1):16-8. (PMID: 56163)
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9194-9. (PMID: 15967997)
Endocrinology. 2005 Mar;146(3):1226-35. (PMID: 15591153)
Nat Cell Biol. 2017 Aug;19(8):891-903. (PMID: 28714970)
Bone. 2019 Jan;118:89-98. (PMID: 29366839)
Nat Commun. 2015 Aug 06;6:7808. (PMID: 26245716)
J Lipid Res. 2008 Sep;49(9):2055-62. (PMID: 18509197)
J Bone Miner Res. 2016 Jan;31(1):40-51. (PMID: 26332798)
Vet Pathol. 2011 May;48(3):642-54. (PMID: 21051554)
Eur J Endocrinol. 2012 Jun;166(6):1087-91. (PMID: 22408124)
J Bone Miner Res. 2010 Sep;25(9):2078-88. (PMID: 20229598)
J Clin Densitom. 2014 Jan-Mar;17(1):163-9. (PMID: 23522982)
Radiat Res. 2009 Mar;171(3):283-9. (PMID: 19267555)
J Magn Reson Imaging. 2007 Sep;26(3):787-93. (PMID: 17729356)
Osteoporos Int. 2007 May;18(5):641-7. (PMID: 17139464)
Scott Med J. 1986 Jul;31(3):206-7. (PMID: 3798090)
J Oral Maxillofac Surg. 2016 Jan;74(1):190-9. (PMID: 26253013)
J Clin Invest. 2019 May 6;129(6):2404-2416. (PMID: 31063988)
Blood Cells. 1991;17(3):527-49. (PMID: 1760560)
Virchows Arch A Pathol Anat Histol. 1977 Jun 23;374(3):239-47. (PMID: 142350)
Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18656-61. (PMID: 24167256)
PLoS One. 2013 May 31;8(5):e64952. (PMID: 23741433)
Histochem Cell Biol. 2009 Sep;132(3):281-91. (PMID: 19557427)
Bone Rep. 2018 Apr 19;8:204-214. (PMID: 29955639)
Endocrinology. 2016 Feb;157(2):508-21. (PMID: 26696121)
Nature. 2009 Jul 9;460(7252):259-63. (PMID: 19516257)
Calcif Tissue Int. 2020 Apr;106(4):431-443. (PMID: 31901965)
Nat Cell Biol. 2017 Nov;19(11):1336-1347. (PMID: 29035359)
J Bone Miner Res. 2015 Jul;30(7):1268-79. (PMID: 25588731)
Calcif Tissue Int. 2004 Oct;75(4):329-37. (PMID: 15549648)
J Clin Endocrinol Metab. 2007 Apr;92(4):1305-10. (PMID: 17264176)
J Clin Endocrinol Metab. 2009 Jun;94(6):2129-36. (PMID: 19318450)
J Bone Miner Res. 2018 Jun;33(6):1154-1165. (PMID: 29444341)
J Cell Physiol. 2015 Sep;230(9):2032-7. (PMID: 25663195)
J Bone Miner Res. 2002 Jun;17(6):1044-50. (PMID: 12054159)
J Bone Miner Res. 2020 Jan;35(1):106-115. (PMID: 31509274)
J Clin Endocrinol Metab. 2014 Aug;99(8):E1493-500. (PMID: 25070319)
J Bone Miner Res. 2020 Jun;35(6):1031-1039. (PMID: 32078187)
JCI Insight. 2019 Jul 11;4(13):. (PMID: 31292295)
Calcif Tissue Int. 2001 Apr;68(4):248-54. (PMID: 11353953)
Int J Exp Pathol. 2009 Oct;90(5):512-9. (PMID: 19765105)
Blood. 2017 Mar 9;129(10):1320-1332. (PMID: 28049638)
J Clin Densitom. 2016 Apr-Jun;19(2):180-91. (PMID: 25440183)
J Bone Miner Res. 2019 Apr;34(4):711-725. (PMID: 30615803)
Bone. 2013 Mar;53(1):145-53. (PMID: 23246792)
J Endocrinol. 2016 Jun;229(3):295-306. (PMID: 27340200)
Radiology. 2015 Oct;277(1):230-5. (PMID: 25988401)
Endocr Rev. 2015 Apr;36(2):194-213. (PMID: 25738213)
Endocrinology. 2007 Jun;148(6):2669-80. (PMID: 17332064)
Grant Information:: R01 AG069795 United States AG NIA NIH HHS; R01 DK121759 United States DK NIDDK NIH HHS; R01 DK125513 United States DK NIDDK NIH HHS; R24 DK092759 United States DK NIDDK NIH HHS
Contributed Indexing:: Keywords: bone; bone marrow adipocyte; bone marrow adipose tissue; hematopoiesis; preclinical models
Entry Date(s):: Date Created: 20210521 Date Completed: 20211101 Latest Revision: 20220716
Update Code:: 20240104
PubMed Central ID:: PMC8458229
DOI:: 10.1016/j.beem.2021.101547
PMID:: 34016532
: Czasopismo naukowe

Full Text Finder

Laboratory mice are a crucial preclinical model system for investigating bone marrow adipocyte (BMAd)-bone and BMAd-hematopoiesis interactions. In this review, we evaluate the suitability of mice to model common human diseases related to osteopenia or hematopoietic disorders, point out consistencies and discrepancies among different studies, and provide insights into model selection. Species, age, sex, skeletal site, and treatment protocol should all be considered when designing future studies.
(Copyright © 2021 Elsevier Ltd. All rights reserved.)

Informacja